Discrimination of ranges of closely related RNA targets using CRISPR-based detection assay developed using machine learning-based optimization
Source check: Source checked. Not independent scientific confirmation.
Finding: The primary publisher Methods/Results support the AI-enabled result: CRISPR-Cas13a assay with ML-designed guide sets discriminating SARS-CoV-2 from twelve sarbecoviruses, validated with in vitro data; distinct assay result with an identified ML design role. The result is reported in the Scientific Reports. Affiliation was not stated in the reviewed material. It does not establish generalization beyond the reported setting or prospective real-world benefit.
Technology: Methods establish the case-specific AI operation: CRISPR-Cas13a assay with ML-designed guide sets discriminating SARS-CoV-2 from twelve sarbecoviruses, validated with in vitro data
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- Methods establish the case-specific AI operation: CRISPR-Cas13a assay with ML-designed guide sets discriminating SARS-CoV-2 from twelve sarbecoviruses, validated with in vitro data
- Test and result
- The primary publisher Methods/Results support the AI-enabled result: CRISPR-Cas13a assay with ML-designed guide sets discriminating SARS-CoV-2 from twelve sarbecoviruses, validated with in vitro data; distinct assay result with an identified ML design role.
- Limitation / still unknown
- Independent replication and prospective real-world benefit are not established in the reviewed study.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.nature.com/articles/s41598-026-78991-4
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.